Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion-Positive Lung Cancer by Combining Selpercatinib with Crizotinib
塞帕替尼联合克唑替尼克服RET融合阳性肺癌患者对选择性RET抑制剂的MET依赖性耐药
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-20-2278
Rosen, Ezra Y; Johnson, Melissa L; Clifford, Sarah E; Somwar, Romel; Kherani, Jennifer F; Son, Jieun; Bertram, Arrien A; Davare, Monika A; Gladstone, Eric; Ivanova, Elena V; Henry, Dahlia N; Kelley, Elaine M; Lin, Mika; Milan, Marina S D; Nair, Binoj C; Olek, Elizabeth A; Scanlon, Jenna E; Vojnic, Morana; Ebata, Kevin; Hechtman, Jaclyn F; Li, Bob T; Sholl, Lynette M; Taylor, Barry S; Ladanyi, Marc; Jänne, Pasi A; Rothenberg, S Michael; Drilon, Alexander; Oxnard, Geoffrey R
